SARS-COV-2 ACUTE RESPIRATORY DISEASE
Clinical trials for SARS-COV-2 ACUTE RESPIRATORY DISEASE explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 ACUTE RESPIRATORY DISEASE trials appear
Sign up with your email to follow new studies for SARS-COV-2 ACUTE RESPIRATORY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COVID booster shows promise in 887-person trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new booster vaccine called PHH-1V in 887 adults who had already received two doses of the Pfizer COVID-19 vaccine. The goal was to see if PHH-1V could safely boost immunity as well as or better than another Pfizer dose. The trial also looked at giving a fourth…
Matched conditions: SARS-COV-2 ACUTE RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 07:35 UTC
-
Adaptive COVID-19 drug combo trial wraps up
Knowledge-focused CompletedThis completed Phase 2 trial tested the safety and effectiveness of different drug combinations in people with COVID-19. It used a master protocol that allowed both hospitalized and non-hospitalized patients to join. Only 4 participants were enrolled, and the study focused on mea…
Matched conditions: SARS-COV-2 ACUTE RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Leidos Life Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC